Vascular Responses to 8‐nitro‐cyclic GMP in Non‐diabetic and Diabetic Mice

Yoshiko Tokutomi,Keiichiro Kataoka,Eiichiro Yamamoto,Taishi Nakamura,Masaya Fukuda,Hisato Nako,Kensuke Toyama,Yi-Fei Dong,Khandaker Ahtesham Ahmed,Tomohiro Sawa,Takaaki Akaike,Shokei Kim-Mitsuyama
DOI: https://doi.org/10.1111/j.1476-5381.2011.01201.x
IF: 7.3
2011-01-01
British Journal of Pharmacology
Abstract:BACKGROUND AND PURPOSE8-Nitroguanosine 3', 5'-cyclic monophosphate (8-nitro-cGMP), formed nitric oxide (NO)-dependently, is a physiological second messenger, yet little is known about its role in the pathophysiology of vascular diseases. To study the pharmacological activity of 8-nitro-cGMP in diabetic mice, we compared its effects on vascular reactivity of aortas from non-diabetic and diabetic mice.EXPERIMENTAL APPROACHVascular tension recording was performed in thoracic aortic rings from wild-type (C57BL/6), non-diabetic db/+ and obese/diabetic db/db mice. Endothelial NO synthase (eNOS) uncoupling and superoxide were tested by Western blot and dihydroethidium fluorescence respectively.KEY RESULTS8-Nitro-cGMP, at concentrations up to 10 mu M, enhanced phenylephrine-induced contractions in aortas from C57BL/6 and db/+ mice, but not from db/db mice. This enhancement was not observed with 8-bromo-cGMP. Pretreatment of aortas from C57BL/6 and db/+ mice with L-NAME (100 mu M), superoxide dismutase (100 U.mL(-1)) or tiron (1 mM), abolished 8-nitro-cGMP-induced enhancement of the phenylephrine contraction. In 8-nitro-cGMP (10 mu M)-treated C57BL/6 aortas, eNOS dimer/monomer ratio was significantly decreased and vascular superoxide production increased, suggesting that 8-nitro-cGMP-induced superoxide production via eNOS uncoupling may mediate the enhancement of the phenylephrine contraction. At higher concentrations (> 10 mu M), 8-nitro-cGMP produced relaxation of the phenylephrine-contracted aortas from C57BL/6, db/+ and db/db mice. The 8-nitro-cGMP-induced relaxation in db/db mouse aortas was found to be resistant to a phosphodiesterase 5 inhibitor, zaprinast (1 mu M).CONCLUSIONS AND IMPLICATIONSThe vasodilator effect of 8-nitro-cGMP may contribute to amelioration of the vascular endothelial dysfunction in diabetic mice, representing a novel pharmacological approach to prevent the complications associated with diabetes.
What problem does this paper attempt to address?